Healing the mental health crisis: The emerging potential of psychedelics
With 1 in 4 people experiencing mental health issues worldwide, we ask this incredible panel of health and tech luminaries, can we solve the mental health crisis with psychedelics?
Catherine Bird – Clinical Trials Manager – Psychedelic Trials Group, King’s College London
Christian Angermayer – Co-founder & Chairman – Apeiron Investment Group
Dr Ekaterina Malievskaia – Chief Innovations Office – COMPASS Pathways
Michael Stothard – Principal – firstminute capital
A new curated social media platform for professionals.
Making sure you’re as prepared as possible for the week ahead.
To find out how CogX can help you radically improve your organisation’s productivity, email email@example.com today.
CogX Festival 2023: Register Your Interest Today